4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-127564
Director sold 19,732 shares at an average $34.14 ($673,748)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kersten Dirk Director | 2024-11-13 | Sale 10b5-1 | −10,803 | $35.24 | $380,698 | 62,301 | I |
| Kersten Dirk Director | 2024-11-14 | Sale 10b5-1 | −8,929 | $32.82 | $293,050 | 5,786,435 | I |
| Open-market sales · 19,732 sh · avg $34.14 · $673,748 | |||||||
Loading xslF345X05/ownership.xml…